See if you are qualify or not to this weight loss journey

Our Treatments

FDA-approved medications

FDA-approved medications

for lasting weight loss

for lasting weight loss

Our licensed physicians will help determine which GLP-1 medication is right for you based on your health history and weight loss goals.

Our licensed physicians will help determine which GLP-1 medication is right for you based on your health history and weight loss goals.

Semaglutide

Ozempic

Ozempic (semaglutide) is an FDA-approved GLP-1 receptor agonist that helps regulate blood sugar levels and promotes weight loss by reducing appetite and slowing digestion.

Reduces appetite naturally

Improves blood sugar control

Weekly injection for convenience

Clinically proven weight loss

Check My Eligibility

Semaglutide

Ozempic

Ozempic (semaglutide) is an FDA-approved GLP-1 receptor agonist that helps regulate blood sugar levels and promotes weight loss by reducing appetite and slowing digestion.

Check My Eligibility

Reduces appetite naturally

Improves blood sugar control

Weekly injection for convenience

Clinically proven weight loss

Semaglutide (higher dose)

Wegovy

Wegovy is the higher-dose version of semaglutide specifically approved for chronic weight management. It works by mimicking a hormone that targets areas of the brain involved in appetite regulation.

FDA-approved for weight loss

Average 15% body weight reduction

Once-weekly self-injection

Sustained long-term results

Check My Eligibility

Tirzepatide

Zepbound

Zepbound (tirzepatide) is the newest FDA-approved medication for chronic weight management. It works by activating both GIP and GLP-1 receptors, offering enhanced weight loss effects.

Dual-action mechanism

Up to 21% average weight loss

Flexible dosing options

Improved metabolic health

Check My Eligibility

Tirzepatide (Single dose)

Zepbound Vial

Zepbound is now available in convenient single-dose vials. This option offers the same clinically proven dual-action formula for weight management with greater flexibility for patients paying out-of-pocket.

Same powerful active ingredient

Cost-effective for self-pay

Precise single-dose control

Enhanced accessibility

Check My Eligibility

Semaglutide

Ozempic

Ozempic (semaglutide) is an FDA-approved GLP-1 receptor agonist that helps regulate blood sugar levels and promotes weight loss by reducing appetite and slowing digestion.

Check My Eligibility

Reduces appetite naturally

Improves blood sugar control

Weekly injection for convenience

Clinically proven weight loss

Semaglutide (higher dose)

Wegovy

Wegovy is the higher-dose version of semaglutide specifically approved for chronic weight management. It works by mimicking a hormone that targets areas of the brain involved in appetite regulation.

FDA-approved for weight loss

Average 15% body weight reduction

Once-weekly self-injection

Sustained long-term results

Check My Eligibility

Tirzepatide

Zepbound

Zepbound (tirzepatide) is the newest FDA-approved medication for chronic weight management. It works by activating both GIP and GLP-1 receptors, offering enhanced weight loss effects.

Dual-action mechanism

Up to 21% average weight loss

Flexible dosing options

Improved metabolic health

Check My Eligibility

Tirzepatide (Single dose)

Zepbound Vial

Zepbound is now available in convenient single-dose vials. This option offers the same clinically proven dual-action formula for weight management with greater flexibility for patients paying out-of-pocket.

Same powerful active ingredient

Cost-effective for self-pay

Precise single-dose control

Enhanced accessibility

Check My Eligibility

Semaglutide (higher dose)

Wegovy

Wegovy is the higher-dose version of semaglutide specifically approved for chronic weight management. It works by mimicking a hormone that targets areas of the brain involved in appetite regulation.

FDA-approved for weight loss

Average 15% body weight reduction

Once-weekly self-injection

Sustained long-term results

Check My Eligibility

Tirzepatide

Zepbound

Zepbound (tirzepatide) is the newest FDA-approved medication for chronic weight management. It works by activating both GIP and GLP-1 receptors, offering enhanced weight loss effects.

Dual-action mechanism

Up to 21% average weight loss

Flexible dosing options

Improved metabolic health

Check My Eligibility

Tirzepatide (Single dose)

Zepbound Vial

Zepbound is now available in convenient single-dose vials. This option offers the same clinically proven dual-action formula for weight management with greater flexibility for patients paying out-of-pocket.

Same powerful active ingredient

Cost-effective for self-pay

Precise single-dose control

Enhanced accessibility

Check My Eligibility

Our Treatments

Which treatment is right for you?

Which treatment is right

for you?

Which treatment is right for you?

Our medical team will help you choose the best option based on your health profile.

Our medical team will help you choose the best option based

on your health profile.

Our medical team will help you choose the best option based on your health profile.

Feature

Feature

Ozempic

Ozempic

Wegovy

Wegovy

Zepbound

Zepbound

Zepbound Vial

Zepbound Vial

Active Ingredient

Active Ingredient

Semaglutide

Semaglutide

Semaglutide

Semaglutide

Tirzepatide

Tirzepatide

Tirzepatide

Tirzepatide

FDA Approved For

FDA Approved For

Type 2 Diabetes

Type 2 Diabetes

Weight Management

Weight Management

Weight Management

Weight Management

Weight Management

Weight Management

Mechanism

Mechanism

GLP-1 Agonist

GLP-1 Agonist

GLP-1 Agonist

GLP-1 Agonist

Dual GIP/GLP-1

Dual GIP/GLP-1

Dual GIP/GLP-1

Dual GIP/GLP-1

Avg. Weight Loss

Avg. Weight Loss

~12%

~12%

~15%

~15%

~21%

~21%

~21%

~21%

Administration

Administration

Weekly Pen

Weekly Pen

Weekly Pen

Weekly Pen

Weekly Pen

Weekly Pen

Single-Dose Vial

Single-Dose Vial

Feature

Ozempic

Wegovy

Zepbound

Zepbound Vial

Active Ingredient

Semaglutide

Semaglutide

Tirzepatide

Tirzepatide

FDA Approved For

Type 2 Diabetes

Weight Management

Weight Management

Weight Management

Mechanism

GLP-1 Agonist

GLP-1 Agonist

Dual GIP/GLP-1

Dual GIP/GLP-1

Avg. Weight Loss

~12%

~15%

~21%

~21%

Administration

Weekly Pen

Weekly Pen

Weekly Pen

Single-Dose Vial

Take The First Step Toward

Your Ideal Weight

Get Started Today

© 2026 TrimTech. All rights reserved.

Take The First Step Toward

Your Ideal Weight

Get Started Today

© 2026 TrimTech. All rights reserved.

See if you are qualify or not to this weight loss journey